Jim Cramer Shares Why Novo Nordisk (NVO) Might Feel The Heat From Eli Lilly
We just covered Jim Cramer Discussed The Iran Ceasefire & Commented On These 19 Stocks. Novo Nordisk A/S (NYSE:NVO) is one of the stocks discussed by Jim Cramer. Novo Nordisk A/S (NYSE:NVO)’s shares are down by 40% over the past year and by 29.6% year-to-date. BMO Capital kept a Market Perform rating and a $45 share price target on the firm on March 30th. The financial firm remained optimistic about the tailwinds from Novo Nordisk A/S (NYSE:NVO)’s Wegovy weight loss pill, but added that the firm neverthel ...